|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1999-5-20
|
|
pubmed:abstractText |
The optimal toxic reaction of the normal tissues in perfused limbs after isolated limb perfusion (ILP) is unknown. Theoretically, more severe limb toxicity could reflect a concomitant increased toxic effect to the tumor and improved outcomes. We determined whether there is a relation between limb toxicity and treatment outcomes after ILP for recurrent limb melanoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1072-7515
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
188
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
522-30
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:10235581-Adolescent,
pubmed-meshheading:10235581-Adult,
pubmed-meshheading:10235581-Aged,
pubmed-meshheading:10235581-Aged, 80 and over,
pubmed-meshheading:10235581-Antineoplastic Agents,
pubmed-meshheading:10235581-Chemotherapy, Cancer, Regional Perfusion,
pubmed-meshheading:10235581-Edema,
pubmed-meshheading:10235581-Erythema,
pubmed-meshheading:10235581-Extremities,
pubmed-meshheading:10235581-Female,
pubmed-meshheading:10235581-Humans,
pubmed-meshheading:10235581-Hyperthermia, Induced,
pubmed-meshheading:10235581-Interferon-gamma,
pubmed-meshheading:10235581-Male,
pubmed-meshheading:10235581-Melanoma,
pubmed-meshheading:10235581-Melphalan,
pubmed-meshheading:10235581-Middle Aged,
pubmed-meshheading:10235581-Multivariate Analysis,
pubmed-meshheading:10235581-Neoplasm Recurrence, Local,
pubmed-meshheading:10235581-Prognosis,
pubmed-meshheading:10235581-Retrospective Studies,
pubmed-meshheading:10235581-Skin Neoplasms,
pubmed-meshheading:10235581-Survival Rate,
pubmed-meshheading:10235581-Treatment Outcome,
pubmed-meshheading:10235581-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma.
|
|
pubmed:affiliation |
Department of Surgery, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Ziekenhuis), Amsterdam.
|
|
pubmed:publicationType |
Journal Article
|
